Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Conference Coverage

Florian Rieder, MD, on Anti-TNF Biosimilars for IBD

Dr Rieder reviews his presentation from the AIBD virtual regional meeting on August 27 on biosimilars for anti-tumor necrosis factor therapies, including ways to overcome the "nocebo effect" among patients.

 

Florian Rieder, MD, is vice chair of gastroenterology and co-section head of the Inflammatory Bowel Disease Center at Cleveland Clinic in Cleveland, Ohio.

Advertisement

Advertisement

Advertisement